ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0807

High Throughput Analyses for the Study of Synovial Tissue Biopsy from Inflammatory Arthritis Patients

Viviana Marzaioli1, Achilleas Floudas2, Aine Gorman3, Carl Orr4, Douglas Veale5 and Ursula Fearon6, 1Trinity College Dublin and University College Dublin, Dublin, Ireland, 2Molecular Rheumatology Trinity Biomedical Sciences Institute, Dublin, Ireland, 3St Vincent's University Hospital, Dublin, Ireland, 4Saint Vincent's University Hospital, Dublin, Ireland, 5St. Vincent's University Hospital, Blackrock, Dublin, Ireland, 6Trinity College Dublin, Dublin, Ireland

Meeting: ACR Convergence 2022

Keywords: immunology, Inflammation, Psoriatic arthritis, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster II

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Inflammatory arthritis (IA) is a chronic systemic autoimmune disease of unknown aetiology, which affects the joints. While studies of immune cell populations in peripheral blood have been informative regarding potential immune cell dysfunction and possible patient stratification, there are considerable limitations in identifying the early events that lead to synovial inflammation. The joint, as the site of inflammation and the local microenvironment, exhibit unique characteristics that contribute to disease pathogenesis. This work aims to provide an overview of high throughput analysis and key methodology for the handling, processing and analysis of ST biopsies and the potential synergy between these techniques.

Methods: Synovial biopsies were obtained from inflammatory arthritis (IA) patients at arthroscopy (St. Vincent’s University Hospital). Paired PBMC were obtained on the same day. Methodology included: flow cytometric analysis, RNA sequencing, ex vivo functional assays (T cell activation and endocytosis). Ethics for this study was approved by the St. Vincent’s University Hospital.

Results: In order to investigate the cellular contribution in the periphery vs the synovial tissue (ST) of IA patients, multi-parameter flow cytometry was utilized. Results suggest that there is an infiltration of specific immune cells into the joint of IA patients, including CD3+T cells and myeloid DC, with a specific decrease in B and CD4+T cells. When correlating to disease activity (DAS28 and CRP), a specific increase in monocyte-derived cells was observed, including CD14+ and CD64+ cells. The further stratification between RA and PsA patients, showed specific disease pathotype-infiltration. The study of T cells poly-functionality in IA ST demonstrated a significant decrease in T cells poly-functionality, as shown by the significant decrease in the co-expression of specific cytokines combination (including IL2+TNFα+GMCSF+IFNγ+ and GMCSF+TNFα+ in cells treated with both the OxPhox inhibitor FCCP or the JAK/STAT inhibitor Tofacitinib. In addition, we optimized a new technique to assess endocytosis in multiple populations simultaneously without the need for cell sorting. Briefly, digested cells were incubated in parallel at 4°C (passive endocytosis) and 37°C (active endocytosis) with DQ OVA(Ovalbumin). ST cells were then stained for multiple populations, demonstrating differential endocytosis capacity between RA and PsA ST CD14+ and mDC. Finally, utilisation of novel bioinformatics analysis of RNAseq data showed differential gene expression and pathway enrichment involved in IA pathogenesis and allowed for the comparison of cell specific enrichment scores and transcription factor usage based on pathotype and gender.

Conclusion: The introduction of new powerful techniques in the study of ST inflammation, brings new challenges and significant opportunities. These approaches will accelerate our path towards understanding of the mechanisms involved in the pathogenesis of IA and lead to the identification of new avenues of therapeutic intervention.


Disclosures: V. Marzaioli, None; A. Floudas, None; A. Gorman, None; C. Orr, None; D. Veale, AbbVie/Abbott, Pfizer, Eli Lilly, Novartis, Gilead; U. Fearon, AbbVie/Abbott, Pfizer, Janssen, Eli Lilly, GlaxoSmithKlein(GSK).

To cite this abstract in AMA style:

Marzaioli V, Floudas A, Gorman A, Orr C, Veale D, Fearon U. High Throughput Analyses for the Study of Synovial Tissue Biopsy from Inflammatory Arthritis Patients [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/high-throughput-analyses-for-the-study-of-synovial-tissue-biopsy-from-inflammatory-arthritis-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-throughput-analyses-for-the-study-of-synovial-tissue-biopsy-from-inflammatory-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology